药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Granisetron
Carindacillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Carindacillin.
Granisetron
Azidocillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Azidocillin.
Granisetron
Ticarcillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Ticarcillin.
Granisetron
Pivmecillinam
The therapeutic efficacy of Vecuronium can be increased when used in combination with Pivmecillinam.
Granisetron
Pivampicillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Pivampicillin.
Granisetron
Meticillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Meticillin.
Granisetron
Bacampicillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Bacampicillin.
Granisetron
Amdinocillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Amdinocillin.
Granisetron
Azlocillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Azlocillin.
Granisetron
Mezlocillin
The therapeutic efficacy of Vecuronium can be increased when used in combination with Mezlocillin.
Granisetron
Benzylpenicilloyl polylysine
The therapeutic efficacy of Vecuronium can be increased when used in combination with Benzylpenicilloyl polylysine.
Granisetron
Pirlimycin
The risk or severity of neuromuscular blockade can be increased when Pirlimycin is combined with Vecuronium.
Granisetron
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Vecuronium.
Granisetron
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Vecuronium.
Granisetron
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Vecuronium.
Granisetron
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Vecuronium.
Granisetron
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Vecuronium.
Granisetron
Ibipinabant
The risk or severity of adverse effects can be increased when Ibipinabant is combined with Vecuronium.
Granisetron
Ajulemic acid
The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Vecuronium.
Granisetron
GW842166
The risk or severity of adverse effects can be increased when GW842166 is combined with Vecuronium.